Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein

Shasta L. Sabo, Lorene M. Lanier, Annat F. Ikin, Olga Khorkova, Sudhir Sahasrabudhe, Paul Greengard, Joseph D. Buxbaum

Research output: Contribution to journalArticlepeer-review

198 Scopus citations


The principal component of Alzheimer's amyloid plaques, Aβ, derives from proteolytic processing of the Alzheimer's amyloid protein precursor (APP). FE65 is a brain-enriched protein that binds to APP. Although several laboratories have characterized the APr-FE65 interaction in vitro, the possible relevance of this interaction to Alzheimer's disease has remained unclear. We demonstrate here that APP and FE65 co-localize in the endoplasmic reticulum/Golgi and possibly in endosomes. Moreover, FE65 increases translocation of APP to the cell surface, as well as both αAPP(s) and Aβ secretion. The dramatic (4-fold) FE65-dependent increase in Aβ secretion suggests that agents which inhibit the interaction of FE65 with APP might reduce Aβ secretion in the brain and therefore be useful for preventing or slowing amyloid plaque formation.

Original languageEnglish (US)
Pages (from-to)7952-7957
Number of pages6
JournalJournal of Biological Chemistry
Issue number12
StatePublished - Mar 19 1999


Dive into the research topics of 'Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein'. Together they form a unique fingerprint.

Cite this